Patents by Inventor Richard B. Mortensen

Richard B. Mortensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030027221
    Abstract: Candidates for biological activity are screened in capsules, each capsule containing a candidate, a target (which may be a molecular species or a biological cell or multiple copies of such a species or cell), and an intelligent substance. The target is one with which a successful candidate will interact to evoke a particular response in the target, and the intelligent substance is one that undergoes a transformation as a result of the response, the transformation being detectable by observation of the capsule itself. The candidate and the target are isolated from each other in the capsule until a designated point in time thereby enabling the operator to control the time interval between exposure of the target to the candidate and the observation of the capsule to determine whether or not a successful interaction has occurred and the transformation has taken place.
    Type: Application
    Filed: April 6, 2001
    Publication date: February 6, 2003
    Inventors: Melissa E. Scott, Haim Kedar, Andrew J. Kelly, David E. Huber, Richard B. Mortensen
  • Patent number: 5541069
    Abstract: An assay for determining the presence of a threshold concentration of an analyte in a sample comprises first reacting the sample with an amount of anti-analyte selected to reduce the free analyte to a marginally detectable concentration. The sample is then contacted with anti-analyte immobilized on a test region or indicator zone on a solid phase, whereby the residual free analyte may be bound. The binding of free analyte to immobilized anti-analyte is detected by a variety of techniques to indicate the presence of the threshold concentration. By employing limited amounts of anti-analyte on the solid phase, the change between maximum binding of label and no binding of label will be responsive to very small changes in the analyte concentration originally present in the sample.
    Type: Grant
    Filed: February 28, 1992
    Date of Patent: July 30, 1996
    Assignee: Quidel Corporation
    Inventors: Richard B. Mortensen, Henry K. Tom
  • Patent number: 5079170
    Abstract: A sample applicator for use in performing immunoassays comprises a tube defining an internal lumen and having a filter matrix at one end thereof. Sample is drawn into the applicator tube, either using a vacuum bulb or an automated assay device. The sample is filtered as it enters the tube, and is again filtered as it discharged from the tube in the opposite flow direction. By removing particulates from the liquid sample, assay performance can be greatly improved. The applicator may also comprise a reagent dispersed within a permeable matrix, which is useful for introducing reagent to a sample or other liquid assay component. As a liquid assay component is drawn into the applicator tube, the reagent is reconstituted by and mixed with the liquid, thereby reducing the number of steps required for the assay.
    Type: Grant
    Filed: October 25, 1990
    Date of Patent: January 7, 1992
    Assignee: Quidel Corporation
    Inventors: Daniel B. Rosman, Douglas D. Rundle, Gary A. Ascani, Richard B. Mortensen, Henry Tom